Coronavirus – USA: severe allergic reaction to Pfizer / BioNTech Health



[ad_1]

Severe allergic reaction an Alaskan health worker appeared after receiving the vaccine of Pfizer and BioNTech for young coronavirus, according to a post by New York Times.

The report, which cites three people with knowledge of the person’s health status, states that the allergic reaction occurred on Tuesday and that the person is in stable condition after being admitted to the hospital.

According to the report, it is not clear whether the vaccinated person had history of allergic reactions. Pfizer did not immediately respond to a request for comment.

US authorities are working with Pfizer Inc. to help maximize production of the Covid-19 vaccine, after the pharmaceutical company announced it could face “Challenges” in production said today the Secretary of Health of the United States, Alex Azar.

Pfizer did not respond to a request for comment. However, earlier this week o Albert Mockery, the company’s chief executive, told CNBC that he had asked the US government. Defense Production Law to remove some critics “Supply restrictions”, especially for some ingredients. However, it did not elaborate on possible shortcomings.

US officials did not specify what the specific “challenges” to the production were. However, they said they know the materials and equipment necessary for the production of vaccines, from the experience they have from their cooperation with other pharmaceutical companies.

“They have recently informed us about the various challenges they may face in production and we will ensure that, through whatever mechanism is necessary, we will provide our full support to ensure production for the American people,” Azar said.

At the same telephone press conference, Dr Moncef Sloui, US Operation Speed ​​Vortex advisor, said that the US government was in talks with Pfizer to secure an additional 100 million doses of your vaccine.

Earlier, officials said the United States had already signed purchase agreements. 300 million doses of Pfizer / BioNTech and Moderna and a total of 900 million doses from pharmaceutical companies developing vaccines for Covid-19. They added that the Moderna vaccine is likely to receive approval from authorities on Friday.

[ad_2]